Update on the intercontinental cooperative ITP study group (ICIS) and on the pediatric and adult registry on chronic ITP (PARC ITP)

Pediatric Blood and Cancer

Volumn 60, Issue SUPPL.1, 2013, Pages

  Kühne, Thomas ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Blood platelets; Immune thrombocytopenia; Registry

Indexed keywords

BLEEDING TENDENCY; CLINICAL RESEARCH; CYTOTOXIC LYMPHOCYTE; DIAGNOSTIC PROCEDURE; DISEASE REGISTRY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REGULATORY T LYMPHOCYTE; REMISSION; REVIEW; SPLENECTOMY; T LYMPHOCYTE; TH1 CELL; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

ADULT; BLOOD PLATELETS; CHILD; HEMORRHAGE; HUMANS; INTERNATIONAL COOPERATION; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REGISTRIES; SPLENECTOMY;

EID: 84869228561     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24342     Document Type: Review

References (22)

1. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura (ITP) of adults and children. Report from an international working group. Blood 2009; 113: 2386-2393.
2. McMillan R, Wang L, Tomer A, et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2004; 103: 1364-1369.
3. Chang M, Nakagawa PA, Williams SA, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 2003; 102: 887-895.
4. Imbach P, Kühne T, Müller D, et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 2006; 46: 351-356.
5. Kühne T, Imbach P, Bolton-Maggs PHB, et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: An observational study. Lancet 2001; 358: 2122-2125.
6. Neunert CE, Buchanan GR, Imbach P, et al. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 2008; 112: 4003-4008.
7. Olsson B, Andersson PO, Jernås M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 2003; 9: 1123-1124.
8. Roark JH, Bussel JB, Cines DB, et al. Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood 2002; 100: 1388-1398.
9. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for The American Society of Hematology. Blood 1996; 88: 3-40.
10. Imbach P, Kühne T, Blanchette V, guest editors. Intercontinental Childhood ITP Study Group (ICIS): State-of-the-Art Expert Meeting on ITP, September 23-25, 2003-Buergenstock, Switzerland. J Pediatr Hematol Oncol 2003; 25: 1-84.
11. Kühne T, Imbach P, guest editors. 2nd Intercontinental Childhood ITP Study Group (ICIS) Expert Meeting on "Critical Issues, Future Research of ITP, " September 16-18, 2006, Yverdon, Switzerland. Pediatr Blood Cancer 2006; 47: 649-745.
12. Kühne T, Imbach P, guest editors. 3rd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting on Consensus and Development of Strategies in ITP. Basel, Switzerland, September 3-5, 2009. Ann Hematol 2010; 89: 1-109.
13. Kühne T, Buchanan GR, Zimmerman S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from The Intercontinental Childhood ITP Study Group. J Pediatr 2003; 143: 605-608.
14. Kühne T, Blanchette V, Buchanan GR, et al. Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group. Pediatr Blood Cancer 2007; 49: 829-834.
15. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168-186.
16. Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-4207.
17. Tamminga R, Berchtold W, Bruin M, et al. Possible lower rate of chronic ITP after IVIG for acute childhood ITP. An analysis from Registry I of the Intercontinental Cooperative ITP Study Group (ICIS). Br J Haematol 2009; 146: 180-184.
18. Kühne T, Berchtold W, Michaels LA, et al. Newly diagnosed immune thrombocytopenia in children and adults, a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica 2011; 96: 1831-1837.
19. Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: Immediate response to therapy and long-term outcome. J Pediatr 1998; 133: 334-339.
20. Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997; 350: 620-623.
21. Kojouri K, Vesely SK, Terrell DR, et al. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004; 104: 2623-2634.
22. Gliklich RE, Dreyer NA, editors. Registries for evaluating patient outcomes: A user's guide. AHRQ Publication No. 07-EHC001-1. Rockville, MD: Agency for Healthcare Research and Quality; 2007. 228 p.